Inflammasomes in Intestinal Inflammation and Cancer

Slides:



Advertisements
Similar presentations
Anatomy of an Inflammasome
Advertisements

Hal M. Hoffman, MD, Lori Broderick, MD, PhD 
Mechanism of Action of Colchicine in the Treatment of Gout
Inna S. Afonina, Christina Müller, Seamus J. Martin, Rudi Beyaert 
The inflammasome in liver disease
Volume 143, Issue 1, Pages (July 2012)
Regulation of inflammasomes by autophagy
Volume 139, Issue 2, Pages e3 (August 2010)
Therapy of autoinflammatory syndromes
Cryopyrin: In from the Cold
NOD-like and Toll-like receptors or inflammasomes contribute to kidney disease in a canonical and a non-canonical manner  Hans-Joachim Anders, Maciej.
Microbial Influences in Inflammatory Bowel Diseases
The Multifaceted Role of the Intestinal Microbiota in Colon Cancer
Nader Yatim, Matthew L. Albert  Immunity 
Gut Microbiota: Mining for Therapeutic Potential
Volume 133, Issue 2, Pages (August 2007)
Figure 3 Molecular mechanisms of crystal-induced necroinflammation
Tumor necrosis factor: Biology and therapeutic inhibitors
Volume 145, Issue 2, Pages e10 (August 2013)
Hal M. Hoffman, MD, Lori Broderick, MD, PhD 
The Gastrointestinal Tract and AIDS Pathogenesis
Autoinflammatory Skin Disorders: The Inflammasome in Focus
Nat. Rev. Nephrol. doi: /nrneph
Benoit Chassaing, Arlette Darfeuille–Michaud  Gastroenterology 
Volume 145, Issue 2, Pages e10 (August 2013)
Mechanism and Regulation of NLRP3 Inflammasome Activation
Volume 151, Issue 4, Pages (October 2016)
Pyroptosis Current Biology
Dieter Demon, Lieselotte Vande Walle, Mohamed Lamkanfi 
Inflammation, Autophagy, and Obesity: Common Features in the Pathogenesis of Pancreatitis and Pancreatic Cancer  Ilya Gukovsky, Ning Li, Jelena Todoric,
Guardians of the Gut: Newly Appreciated Role of Epithelial Toll-Like Receptors in Protecting the Intestine  Matam Vijay-Kumar, Andrew T. Gewirtz  Gastroenterology 
The Intestinal Immune System in Obesity and Insulin Resistance
A Liver Full of JNK: Signaling in Regulation of Cell Function and Disease Pathogenesis, and Clinical Approaches  Ekihiro Seki, David A. Brenner, Michael.
Benjamin L. Woolbright, Hartmut Jaeschke  Journal of Hepatology 
Volume 141, Issue 1, Pages (July 2011)
Volume 139, Issue 6, Pages (December 2010)
The Genetics of Inflammatory Bowel Disease
Staying Alive: Cell Death in Antiviral Immunity
The Stromal Intervention: Regulation of Immunity and Inflammation at the Epithelial- Mesenchymal Barrier  Roni Nowarski, Ruaidhrí Jackson, Richard A. Flavell 
Effects of air pollutants on innate immunity: The role of Toll-like receptors and nucleotide-binding oligomerization domain–like receptors  Rebecca N.
Volume 146, Issue 7, Pages (June 2014)
Chengcheng Jin, Jorge Henao-Mejia, Richard A. Flavell  Cell Metabolism 
Anti-inflammatory Agents: Present and Future
Innate sensors of pathogen and stress: Linking inflammation to obesity
Vaccinating Against Helicobacter pylori: Dissecting the Mechanism
The P2X7 Receptor in Infection and Inflammation
Dangerous Liaisons: Mitochondrial DNA Meets the NLRP3 Inflammasome
The Fire Within: Microbes Inflame Tumors
Roles of Caspases in Necrotic Cell Death
Volume 139, Issue 4, Pages (October 2010)
Figure 1 NLRP3 inflammasome formation pathways
Volume 141, Issue 1, Pages (July 2011)
The Gastrointestinal Tumor Microenvironment
Therapeutic strategies in inflammasome mediated diseases of the liver
Interleukin-18 in Intestinal Inflammation: Friend and Foe?
Qiuhe Lu, Shan Li, Feng Shao  Trends in Microbiology 
Inflammasome Complexes: Emerging Mechanisms and Effector Functions
Inflammation, ROS, and Mutagenesis
Christoph Becker, Alastair J. Watson, Markus F. Neurath 
Mechanisms and Functions of Inflammasomes
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease
Intracellular NOD-like Receptors in Host Defense and Disease
Learning Tolerance while Fighting Ignorance
Sachin P. Gadani, James T. Walsh, John R. Lukens, Jonathan Kipnis 
Proteus mirabilis: The Enemy Within
The End and After: How Dying Cells Impact the Living Organism
Tumor necrosis factor: Biology and therapeutic inhibitors
Clara Abraham, Ruslan Medzhitov  Gastroenterology 
The Tuning of the Gut Nervous System by Commensal Microbiota
Presentation transcript:

Inflammasomes in Intestinal Inflammation and Cancer Grace Y. Chen, Gabriel Núñez  Gastroenterology  Volume 141, Issue 6, Pages 1986-1999 (December 2011) DOI: 10.1053/j.gastro.2011.10.002 Copyright © 2011 AGA Institute Terms and Conditions

Figure 1 Inflammasome components and assembly. With the exception of Aim2 (not shown), all known inflammasomes consist of an NLR, which contain either a PYD domain or a CARD domain that can physically interact with the PYD or CARD domain of ASC and caspase-1, respectively. Nlrp1 and Nlrc4 each contain a CARD domain that can directly interact with caspase-1 independently of ASC; however, the addition of ASC in the inflammasome assembly can enhance its activity in the case of Nlrp1. The Nlrp3 inflammasome, on the other hand, can form different inflammasome complexes, depending on the requirement for ASC.115 Oligomerization of ASC and the NLR results in a macromolecular complex consisting of multiple subunits that are capable of cleaving pro-caspase-1 to its active form, resulting in the cleavage of the pro-forms of IL-1β and IL-18 to their mature, biologically active forms. Activation of caspase-1 also leads to pyroptosis. Gastroenterology 2011 141, 1986-1999DOI: (10.1053/j.gastro.2011.10.002) Copyright © 2011 AGA Institute Terms and Conditions

Figure 2 Activation of the Nlrp3 inflammasome requires 2 steps. (A) Priming step. Based primarily on studies of Nlrp3, inflammasome activity requires first the production of pro-IL-1β and Nlrp3 through up-regulation of nuclear factor κB by activation of either the TLRs or Nod1/2. Inflammatory cytokines such as tumor necrosis factor α or IL-1 can also induce nuclear factor κB. In addition, this first signal (ie, cytokines, TLR, or Nod1/2 activation) also results in the transcriptional up-regulation of Nlrp3. (B) Activation step. It remains unclear how Nlrp3 is activated by diverse signals. Different mechanisms have been proposed: (1) intracellular potassium depletion by the opening of a pore via ATP-dependent P2X7R activation or microbial pore-forming toxins; (2) lysosomal membrane damage and release of activated cathepsin B after endocytosis of sterile particulates such as silica, asbestos, and cholesterol crystals; and (3) generation of ROS from the mitochondria as a consequence of cellular injury (although ROS may affect inflammasome priming only). Gastroenterology 2011 141, 1986-1999DOI: (10.1053/j.gastro.2011.10.002) Copyright © 2011 AGA Institute Terms and Conditions

Figure 3 IL-18 is important for intestinal epithelial repair. Nlrp3-, ASC- and caspase-1–deficient mice have increased susceptibility to DSS-induced colitis. DSS causes direct epithelial injury, increasing permeability and translocation of bacteria into the breached mucosa, leading to an inflammatory response that includes the recruitment of immune cells such as macrophages and neutrophils. The production of IL-18, such as by the Nlrp3 inflammasome, allows the epithelium to be fully restituted, limiting the extent of inflammation. The precise cellular source of IL-18, and the mechanisms by which IL-18 promotes epithelial repair (eg, whether it acts directly on the epithelial cell or indirectly through lamina propria cells), are not known. Gastroenterology 2011 141, 1986-1999DOI: (10.1053/j.gastro.2011.10.002) Copyright © 2011 AGA Institute Terms and Conditions

Figure 4 Model of Nlrp6-mediated regulation of intestinal and microbial homeostasis. Nlrp6 maintains intestinal homeostasis by regulating the composition of the gut microbiome and the production of IL-18 (left). In the absence of Nlrp6 (right), there is dysbiosis, resulting in the accumulation of colitogenic bacteria, up-regulation of inflammatory mediators, such as CCL5, and subclinical inflammation. On additional epithelial damage by DSS, inflammation ensues as a result of impaired epithelial repair from reduced IL-18 production. Gastroenterology 2011 141, 1986-1999DOI: (10.1053/j.gastro.2011.10.002) Copyright © 2011 AGA Institute Terms and Conditions

Figure 5 The inflammasome protects against colitis-associated tumorigenesis through multiple mechanisms. Mice deficient in inflammasome activity have increased susceptibility to colitis-associated tumorigenesis. Specifically, Nlrp3, Nlrc4, and Nlrp6 negatively regulate colitis-associated tumorigenesis (see text for details). Bone marrow chimera experiments indicated that Nlrp3 and Nlrp6 mediate tumor suppression within the hematopoietic compartment. However, mouse chimera experiments indicated that a nonhematopoietic compartment (epithelial or stromal cells) is important for Nlrc4-mediated tumor suppression. Although the mechanism still remains unclear, IL-18 might protect against neoplasia by Nlrp3 and Nlrp6. Unlike Nlrp3 and Nlrp6, the absence of Nlrc4 signaling is not associated with increased inflammation. Instead, Nlrc4 appears to limit tumor development by regulating epithelial proliferation and apoptosis, either in the intestinal epithelium or within the tumor itself. Gastroenterology 2011 141, 1986-1999DOI: (10.1053/j.gastro.2011.10.002) Copyright © 2011 AGA Institute Terms and Conditions